Tools
Tools
Mohan, Vishnu, Gaffney, Jean P., Solomonov, Inna, Levin, Maxim, Klepfish, Mordehay, Akbareian, Sophia, Grünwald, Barbara, Dym, Orly, Eisenstein, Miriam, Yu, Kenneth H., Kelsen, David P., Krüger, Achim, Edwards, Dylan R. 
ORCID: https://orcid.org/0000-0002-3292-2064 and Sagi, Irit
(2021)
Conformation-specific inhibitory anti-MMP-7 monoclonal antibody sensitizes pancreatic ductal adenocarcinoma cells to chemotherapeutic cell kill.
Cancers, 13 (7).
ISSN 2072-6694
Preview |
PDF (Published_Version)
- Published Version
Available under License Creative Commons Attribution. Download (3MB) | Preview |
Abstract
Matrix metalloproteases (MMPs) undergo post-translational modifications including pro-domain shedding. The activated forms of these enzymes are effective drug targets, but generating potent biological inhibitors against them remains challenging. We report the generation of anti-MMP-7 inhibitory monoclonal antibody (GSM-192), using an alternating immunization strategy with an active site mimicry antigen and the activated enzyme. Our protocol yielded highly selective anti-MMP-7 monoclonal antibody, which specifically inhibits MMP-7′ s enzyme activity with high affinity (IC50 = 132 ± 10 nM). The atomic model of the MMP-7-GSM-192 Fab complex exhibited antibody binding to unique epitopes at the rim of the enzyme active site, sterically preventing entry of substrates into the catalytic cleft. In human PDAC biopsies, tissue staining with GSM-192 showed characteristic spatial distribution of activated MMP-7. Treatment with GSM-192 in vitro induced apoptosis via stabilization of cell surface Fas ligand and retarded cell migration. Co-treatment with GSM-192 and chemotherapeutics, gemcitabine and oxaliplatin elicited a synergistic effect. Our data illustrate the advantage of precisely targeting catalytic MMP-7 mediated disease specific activity.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | drug synergy,fas ligand,gemcitabine,matrilysin,matrix metalloproteinase-7,monoclonal antibody,oxaliplatin,pancreatic ductal adeno-carcinoma,oncology,cancer research,sdg 3 - good health and well-being ,/dk/atira/pure/subjectarea/asjc/2700/2730 |
| Faculty \ School: | Faculty of Science > School of Biological Sciences Faculty of Medicine and Health Sciences > Norwich Medical School |
| UEA Research Groups: | Faculty of Medicine and Health Sciences > Research Centres > Norwich Institute for Healthy Aging Faculty of Medicine and Health Sciences > Research Groups > Cancer Studies |
| Related URLs: | |
| Depositing User: | LivePure Connector |
| Date Deposited: | 16 Apr 2021 23:58 |
| Last Modified: | 21 Apr 2023 01:00 |
| URI: | https://ueaeprints.uea.ac.uk/id/eprint/79808 |
| DOI: | 10.3390/cancers13071679 |
Downloads
Downloads per month over past year
Actions (login required)
 |
View Item |